BXP — Beximco Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- £162.83m
- £210.03m
- BDT44.39bn
- 92
- 98
- 83
- 100
REG - Beximco Pharmaceut - Launch of world’s first generic molnupiravir
AnnouncementREG - Beximco Pharmaceut - Results for the year ended 30 June 2021
AnnouncementREG - Beximco Pharmaceut - Notification of Preliminary Results and AGM
AnnouncementREG - Beximco Pharmaceut - Update on the supply of COVID-19 vaccine
AnnouncementREG - Beximco Pharmaceut - Completion of Sanofi Bangladesh Acquisition
AnnouncementREG - Beximco Pharmaceut - Sanofi Bangladesh Share Purchase Agreement signed
AnnouncementREG - Beximco Pharmaceut - Acquisition Approved by Bangladesh Bank
AnnouncementREG - Beximco Pharmaceut - Statement re: media comment
AnnouncementRCS - Beximco Pharmaceut - FDA approval for muscle relaxant drug Baclofen
AnnouncementREG - Beximco Pharmaceut - Update on the supply of COVID-19 vaccine
AnnouncementREG - Beximco Pharmaceut - Q3 Financial Results
AnnouncementREG - Beximco Pharmaceut - Update on the supply of COVID-19 vaccine
AnnouncementREG - Beximco Pharmaceut - Second Price Monitoring Extn
AnnouncementREG - Beximco Pharmaceut - Price Monitoring Extension
AnnouncementREG - Beximco Pharmaceut - Second Price Monitoring Extn
AnnouncementREG - Beximco Pharmaceut - Price Monitoring Extension
AnnouncementREG - Beximco Pharmaceut - Second Price Monitoring Extn
AnnouncementREG - Beximco Pharmaceut - Price Monitoring Extension
AnnouncementREG - Beximco Pharmaceut - Update on the supply of COVID-19 vaccine
Announcement